Clinical responses to Cidofovir applied topically to women with high grade vulval intraepithelial neoplasia

Gynecologic Oncology

Volumn 99, Issue 3, 2005, Pages 652-655

  Tristram, Amanda ^a   Fiander, Alison ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Anogenital intraepithelial neoplasia; Cidofovir; Human papillomavirus; Topical treatment; Vulval intraepithelial neoplasia

Indexed keywords

CIDOFOVIR;

ADULT; AGED; ANTIVIRAL ACTIVITY; ARTICLE; BIOPSY; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; MEASUREMENT; MEDICAL PHOTOGRAPHY; PRIORITY JOURNAL; SYMPTOM; ULCER; VAGINA TUMOR; VULVA CANCER; VULVA DISEASE;

ADMINISTRATION, TOPICAL; ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA IN SITU; CYTOSINE; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PHOSPHONIC ACIDS; VULVAR NEOPLASMS;

EID: 28144438815     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.07.127     Document Type: Article

References (30)

1. J. Buscema, J.D. Woodruff, and T.H. Parmley Carcinoma in situ of the vulva Obstet. Gynecol. 55 2 1980 225 230
2. J.D. Woodruff Carcinoma in situ of the vulva Clin. Obstet. Gynecol. 34 3 1991 669 676
3. R.W. Jones, and D.M. Rowan Vulvar intraepithelial neoplasia 3: a clinical study of the outcome in 113 cases with relation too the later development of invasive vulvar carcinoma Obstet. Gynecol. 84 5 1994 741 745
4. J.J.O. Herod, M.I. Shafi, and T.P. Rollason Vulvar intraepithelial neoplasia: long term follow up of treated and untreated women Br. J. Obstet. Gynaecol. 103 1996 446 452
5. V. Kuppers, M. Stiller, and T. Somville Risk factors for recurrent VIN. Role of multifocality and grade of disease J. Reprod. Med. 42 3 1997 140 144
6. A. Rodolakis, E. Diakomanolis, and G. Vlachos Vulvar intraepithelial neoplasia (VIN)-Diagnostic and therapeutic challenges Eur. J. Gynaecol. Oncol. 24 3-4 2003 317 322
7. E.G. Friedrich Jr., E.J. Wilkinson, and Y.S. Fu Carcinoma in situ of the vulva: a continuing challenge Am. J. Obstet. Gynecol. 136 7 1980 830 843
8. U. Hording, J. Junge, and H. Poulsen Vulvar intraepithelial neoplasia III: a viral disease of undetermined progressive potential Gynecol. Oncol. 56 1995 276 279
9. S.C. Modesitt, A.B. Waters, and L. Walton Vulvar intraepithelial neoplasia III: occult cancer and the impact of margin status on recurrence Obstet. Gynecol. 92 6 1998 962 966
10. J.P. Forney, C.P. Morrow, and D.E. Townsend Management of carcinoma in situ of the vulva Am. J. Obstet. Gynecol. 127 8 1977 801 806
11. N. Husseinzadeh, and C. Recinto Frequency of invasive cancer in surgically excised vulvar lesions with intraepithelial neoplasia (VIN 3) Gynecol. Oncol. 73 1 1999 119 120
12. M. Sideri, L. Spinaci, and N. Spolti Evaluation of CO(2) laser excision or vaporization for the treatment of vulvar intraepithelial neoplasia Gynecol. Oncol. 75 2 1999 277 281
13. R.W. Jones, and D.M. Rowan Spontaneous regression of vulvar intraepithelial neoplasia 2-3 Obstet. Gynecol. 96 3 2000 470 472
14. P. Sykes, N. Smith, and P. McCormick High-grade vulval intraepithelial neoplasia (VIN 3): a retrospective analysis of patient characteristics, management, outcome and relationship to squamous cell carcinoma of the vulva 1989-1999 Aust. N. Z. J. Obstet. Gynaecol. 42 1 2002 69 74
15. E.J. Davidson, C.M. Boswell, and P. Sehr Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins Cancer Res. 63 18 2003 6032 6041
16. P.J. Baldwin, S.H. van der Burg, and C.M. Boswell Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia Clin. Cancer Res. 9 14 2003 5205 5213
17. K.L. Smith, A. Tristram, and K.M. Gallagher Epitope specificity and longevity of a vaccine induced human T cell response against HPV18 Int. Immunol. 17 2 2005 167 176
18. L.J. Smyth, M.I. Van Poelgeest, and E.J. Davidson Immunological responses in women with human papillomavirus type 16 (HPV-16)-associated anogenital intraepithelial neoplasia induced by heterologous prime-boost HPV-16 oncogene vaccination Clin. Cancer Res. 10 9 2004 2954 2961
19. E.S. Abdel-Hady, P. Martin-Hirsch, and M. Duggan-Keen Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy Cancer Res. 61 1 2001 192 196
20. M.K. Fehr, R. Hornung, and A. Degen Photodynamic therapy of vulvar and vaginal condyloma and intraepithelial neoplasia using topically applied 5-aminolevulinic acid Lasers Surg. Med. 30 4 2002 273 279
21. G. Davis, J. Wentworth, and R. J Self-administered topical imiquimod treatment of vulvar intraepithelial neoplasia. A report of four cases J. Reprod. Med. 45 8 2000 619 623
22. C. Jayne, and R.H. Kaufman Treatment of vulvar intraepithelial neoplasia 2/3 with imiquimod J. Reprod. Med. 47 5 2002 395 398
23. R. Todd, I. Etherington, and D. Luesley The effects of 5% imiquimod cream on high-grade vulval intraepithelial neoplasia Gynecol. Oncol. 85 1 2002 67 70
24. M. van Seters, G. Fons, and M. van Beurden Imiquimod in the treatment of multifocal vulvar intraepithelial neoplasia 2/3. Results of a pilot study J. Reprod. Med. 47 9 2002 701 705
25. G. Andrei, R. Snoeck, and D. Schols Induction of apoptosis by cidofovir in human papillomavirus (HPV)-positive cells Oncol. Res. 12 9-10 2001 397 408
26. B. Abdulkarim, S. Sabri, and E. Deutsch Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers Oncogene 21 15 2002 2334 2346
27. R. Snoeck, J.C. Noel, and C. Muller Cidofovir, a new approach for the treatment of cervix intraepithelial neoplasia grade III (CIN III) J. Med. Virol. 60 2 2000 205 209
28. S. Koonsaeng, C. Verschraegen, and R. Freedman Successful treatment of recurrent vulvar intraepithelial neoplasia resistant to interferon and isotretinoin with cidofovir J. Med. Virol. 64 2 2001 195 198
29. M.V. Jacobs, P.J. Snijders, and F.J. Voorhorst Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison [published erratum appears in J Clin Pathol 1999 Oct; 52 (10): 790] J. Clin. Pathol. 52 7 1999 498 503
30. C.J. Jayne, and R.H. Kaufman Treatment of vulvar intraepithelial neoplasia 2/3 with imiquimod J. Reprod. Med. 47 5 2002 395 398